Quick answers
- What is Cefadroxil used for?
- The FDA-approved label (Cefadroxil, Proficient Rx LP, June 1, 2026) says: “Cefadroxil Capsules USP are indicated for the treatment of patients with infection caused by susceptible strains of the designated organisms in the following diseases: Urinary tract infections caused by E. coli, P. mirabilis, and Klebsiella species. Skin and skin structure infections caused by staphylococci and/or streptococci. …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Cefadroxil have a boxed warning?
- No. None of the 36 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Cefadroxil?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Cefadroxil been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Cefadroxil?
- 17 companies list prescription products of Cefadroxil in the FDA NDC Directory, including NuCare Pharmaceuticals, Inc., Bryant Ranch Prepack and Aurobindo Pharma Limited.
What Cefadroxil is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Cefadroxil Capsules USP are indicated for the treatment of patients with infection caused by susceptible strains of the designated organisms in the following diseases: Urinary tract infections caused by E. coli, P. mirabilis, and Klebsiella species. Skin and skin structure infections caused by staphylococci and/or streptococci. …
— FDA label: Cefadroxil, Proficient Rx LP, effective June 1, 2026. Read the full label on DailyMed →
The FDA has 36 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 36 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Capsule · Powder, for suspension · Tablet |
|---|---|
| Route | Oral |
| Prescription products | 40 in the FDA NDC Directory |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| cefadroxil 1000 mg tablet | Generic | $3.40 per tablet |
| cefadroxil 250 mg/5 mL powder, for suspension | Generic | $0.1632 per mL |
| cefadroxil 500 mg capsule | Generic | $0.2719 per capsule |
| cefadroxil 500 mg/5 mL powder, for suspension | Generic | $0.2173–$0.2533 per mL 8 packages, lowest to highest |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- NuCare Pharmaceuticals, Inc.5 products
- Bryant Ranch Prepack4 products
- Aurobindo Pharma Limited3 products
- Redpharm Drug3 products
- Lupin Pharmaceuticals, Inc.3 products
- Direct_Rx3 products
- Rising Pharma Holdings, Inc.3 products
- NorthStar Rx LLC3 products
- PD-Rx Pharmaceuticals, Inc.2 products
- Advanced Rx Pharmacy of Tennessee, LLC2 products
- Preferred Pharmaceuticals Inc.2 products
- Teva Pharmaceuticals USA, Inc.2 products
- Proficient Rx LP1 product
- RedPharm Drug, Inc.1 product
- Remedyrepack Inc.1 product
- A-S Medication Solutions1 product
- Advanced Rx of Tennessee, LLC1 product
FDA approval history
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
Generic approvals (6)
- ANDA062774Teva Pharms · April 8, 1987
- ANDA065282Teva Pharms · January 20, 2006
- ANDA065352Aurobindo Pharma · January 25, 2007
- ANDA065392Lupin · May 29, 2007
- ANDA065396Lupin · February 21, 2008
- ANDA065349Aurobindo · April 25, 2013
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
| RxCUI (RxNorm) | 105171, 309047, 309048, 309049 |
|---|---|
| SPL set ID of the quoted label | 57eebea5-28b6-44a3-888b-76950f6038f4 |
| FDA labels (SPL) | 36 |
| FDA applications | 6 ANDA |
| Active ingredients (FDA) | CEFADROXIL |
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Cefadroxil, Proficient Rx LP, effective June 1, 2026; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →